Responses
Interventional cardiology and surgery
Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial)
Compose a Response to This Article
Other responses
No responses have been published for this article.